课题基金 / 基金详情

Regulation of T cell function and Autoimmunity by Mgat5

Regulation of T cell function and Autoimmunity by Mgat5
Mgat5 对 T 细胞功能和自身免疫的调节
批准号:
6986182
负责人:
MICHAEL DEMETRIOU
金额:
$29.78万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2007-11-30

项目摘要

项目成果

MICHAEL DEMETRIOU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):多发性硬化症(MS)是一种中枢神经系统自身免疫性疾病,导致轴突的多灶性脱髓鞘和相关的轴突损伤。遗传连锁分析已经确定了一些与MS相关的候选基因座,但具有强关联的非MHC基因尚未被确定。MS的动物模型,实验性自身免疫性脑脊髓炎(EAE),是一种T细胞介导的疾病。β 1,6 N-乙酰葡糖胺转移酶V(Mgat 5)是Asn(N)-连接的蛋白质糖基化途径中的酶,是小鼠中T细胞活化和自身免疫的有效负调节剂。Mgat 5缺陷通过直接增强抗原呈递位点的TCR聚集和信号传导来降低T细胞活化阈值。Mgat 5-/- T细胞响应于TCR激动剂而过度增殖,并且Mgat 5缺陷型小鼠显示出对EAE的易感性增加并发展为肾自身免疫性疾病。由Mgat 5引发的GlcNAc α 1,6分支优先通过两个或更多个N-乙酰乳糖胺单位延伸,N-乙酰乳糖胺单位是半乳糖凝集素的配体,半乳糖凝集素是调节T细胞信号传导、增殖和凋亡的碳水化合物结合蛋白家族。TCR相关的Mgat 5修饰的聚糖与半乳糖凝集素-3结合,参与抑制TCR募集至抗原呈递位点的推定的细胞表面半乳糖凝集素-糖蛋白晶格。为了进一步阐明Mgat 5和半乳糖凝集素-糖蛋白晶格在调节T细胞功能和自身免疫中的作用,提出了三个具体目标。具体目标#1将鉴定T细胞半乳糖凝集素-糖蛋白晶格的其他蛋白质和碳水化合物组分及其与T细胞功能和粘附的相关性。通过荧光显微镜、免疫共沉淀、质谱、信号传导和增殖测定,分析从具有糖基化靶向突变的小鼠中分离的T细胞的细胞功能和受体-半乳糖凝集素相互作用的改变。具体目标#2将探索Mgat 5聚糖在TH 1和TH 2 CD 4+、CD 8+和记忆T细胞亚群中的调节和功能。将确定Mgat 5缺乏对自身免疫性疾病的TH 1促进和TH 2抑制之间的平衡的影响。具体目标#3将使用通过过继转移的EAE诱导来确定改变的T细胞粘附和非T细胞对Mgat 5缺陷型自身免疫表型的作用。
英文摘要
DESCRIPTION (provided by applicant): Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that results in multi-focal demyelination of axons and associated axonal damage. Genetic linkage analysis has identified a number of candidate loci associated with MS, but non-MHC genes having a strong association have yet to be identified. The animal model for MS, Experimental Autoimmune Encephalomyelitis (EAE), is a T cell mediated disease. beta1,6N-acetylglucosaminyltransferase V (Mgat5), an enzyme in the Asn (N)-Iinked protein glycosylation pathway, is a potent negative regulator of T cell activation and autoimmunity in mice. Mgat5 deficiency lowers T cell activation thresholds by directly enhancing TCR clustering and signaling at the site of antigen presentation. Mgat5-/- T Cells hyperproliferate in response to TCR agonists and Mgat5 deficient mice display increased susceptibility to EAE and develop kidney autoimmune disease. The GIcNAc a1,6 branching initiated by Mgat5 is preferentially extended by two or more N-acetyllactosamine units, the ligand for galectins, a family of carbohydrate binding proteins that regulate T cell signaling, proliferation and apoptosis. TCR associated Mgat5 modified glycans are bound to galectin-3, participating in a putative cell surface galectin-glycoprotein lattice that inhibits TCR recruitment to the site of antigen presentation. To further elucidate the role of Mgat5 and the galectin-glycoprotein lattice in the regulation of T cell function and autoimmunity, three specific aims are proposed. Specific Aim #1 will identify additional protein and carbohydrate components of the T cell galectin-glycoprotein lattice and their relevance to T cell function and adhesion. T cells isolated from mice with targeted mutations in glycosylation will be analyzed for alterations in cell function and receptor - galectin interactions by florescence microscopy, co-immunoprecipitation, mass spectroscopy, signaling and proliferation assays. Specific Aim #2 will explore the regulation and function of Mgat5 glycans in TH1and TH2 CD4+, CD8+ and memory T cell subsets. The influence of Mgat5 deficiency on the balance between TH1 promotion and TH2 inhibition of autoimmune disease will be determined. Specific Aim #3 will use EAE induction by adoptive transfer to determine the roles of altered T cell adhesion and non-T cells to the Mgat5 deficient autoimmune phenotype.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
  • 批准号:
    10766646
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2023
  • 负责人:
    MICHAEL DEMETRIOU
  • 依托单位:
Cancer Immunotherapy Targeting Tn Antigen
  • 批准号:
    10326021
  • 项目类别:
  • 资助金额:
    $39.82万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL DEMETRIOU
  • 依托单位:
Regulation of B cell function in demyelinating disease by N-glycan branching
  • 批准号:
    10311524
  • 项目类别:
  • 资助金额:
    $50.05万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL DEMETRIOU
  • 依托单位:
Regulation of B cell function in demyelinating disease by N-glycan branching
  • 批准号:
    10535482
  • 项目类别:
  • 资助金额:
    $50.05万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL DEMETRIOU
  • 依托单位:
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位: